Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
3 papers
In a prospective, open-label study of 30 male Special Operations veterans with mostly mild traumatic brain injury, a treatment protocol combining magnesium and oral ibogaine (MISTIC), given with other supportive care, was associated with large, statistically significant improvements in functioning and in clinician-rated PTSD, depression and anxiety scores immediately after…
This paper is a review of recent research on psychedelic drugs. The authors say some clinical trials show these drugs can help people with post-traumatic stress disorder, substance abuse problems, and depression that has not improved with other treatments. But scientists do not yet understand all the biological ways these…
This review looks at studies on using classic psychedelics and nutraceuticals to treat concussion and lasting symptoms after mild traumatic brain injury. Concussion is common in the military, civilians, and contact sport players and usually causes temporary mental impairment, though a small minority have lasting problems. The authors report that…
